The increase in glutathione synthetase activity reached a maximum at 48 hours and started to decrease at 72 hours after Hessian fly infestation
The human evidence is more limited and more mixed
Cleaner numbers mean fewer opportunities for error
Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes (SUSTAIN-6) New England Journal of Medicine In 3,297 patients with T2D, semaglutide reduced major adverse cardiovascular events by 26% versus placebo over 2.1 years (HR 0.74), driven by 39% stroke reduction and 26% nonfatal MI reduction
Sehgal declared having no conflicts of interest.Rudrapatnas research was partially funded by grants to UCSF from the following for-profit entities: Janssen, Merck, Genentech, Alnylam, Takeda, BeOne, Mitsubishi Tanabe, Stryker, and Blueprint Medicines